Trials / Completed
CompletedNCT00949741
Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients
Observational Retrospective Multicenter Study for the Citofluorimetric Analysis of Cerebrospinal Fluid Vs Conventional Method in Patients With Aggressive Non-Hodgkin's Lymphoma Without Leptomeningeal Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 175 (actual)
- Sponsor
- Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to define if flow cytometry has more sensitivity for detecting neoplastic cells in cerebrospinal fluid versus conventional cytology.
Detailed description
Aggressive B-cell non-Hodgkin's lymphoma (B-NHL), Lymphoblastic Lymphoma and Burkitt's Lymphoma are at high risk of CNS relapse. For this reason is recommended a prophylaxis therapy. This suggests that negative leptomeningeal localization patients at diagnosis are really positive and that would be a very high risk of CNS relapse subtype patients. It's very important detecting neoplastic cells in cerebrospinal fluid as soon as possible. This study will evaluate only patients that have been flow cytometry and cytology at diagnosis.
Conditions
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2011-10-01
- Completion
- 2012-10-01
- First posted
- 2009-07-30
- Last updated
- 2013-10-22
Locations
12 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT00949741. Inclusion in this directory is not an endorsement.